A joint effort between 3 Portuguese institutes, including CEDOC-NMS School, warns of 2 mutations in SARSCoV2 spike protein that could elude the immune system.
A joint effort between 3 Portuguese institutes from COLife alliance - led by Instituto Gulbenkian de Ciência in collaboration with ITQB NOVA and CEDOC from NOVA Medical School - warns of 2 mutations in SARSCoV2 spike protein that could elude the immune system. This research was just highlighted at Público
Our own Helena Soares from the Human Immunology and Pathogenesis lab says this research "contributes to be able to predict the immuneresponse; in particular in the production of antibodies, both from patients and vaccinated people, as a response to the new COVID19 variants".
You can read more about this research at the IGC website and the original study published at PLOS Pathogens.